MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
European Urology Oncology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

180 results · 1 filter active ·
Results by year
20182025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
180 works in the cohort · of 4,299,418page 3 of 4

Labels cover 0 of 180 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 180 of 180 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524—A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation
Douglas M. Dahl, Theodore Karrison, M. Dror Michaelson, Huong Pham, Chin‐Lee Wu, Gregory P. Swanson +12 more
2023· article· en· European Urology Oncology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
10
citations
affno abstractunlabeled
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy
Carlo Andrea Bravi, Matteo Droghetti, Nicola Fossati, Giorgio Gandaglia, Nazareno Suardi, Elio Mazzone +28 more
2021· article· en· European Urology Oncology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
9
citations
affunlabeled
Frailty in Older Adults with Prostate Cancer
Neha Pathak, Efthymios Papadopoulos, Vikaash Kumar, Shabbir M.H. Alibhai
2024· review· en· European Urology Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · none
4
citations
affno abstractunlabeled
Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology Guidelines
Bhavan Prasad, Kalpesh Parmar, Benjamin Pradere, Otakar Čapoun, Viktor Soukup, Paolo Gontero +16 more
2025· review· en· European Urology Oncology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
4
citations
affunlabeled
Quality Indicators for Renal Cancer Care: A Systematic Review
Alessio Pecoraro, Sara Costagli, Laura Marandino, Raghav Varma, Maarten Albersen, Umberto Capitanio +10 more
2025· review· en· European Urology Oncology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
4
citations
fundno affunlabeled
PERSEUS1: An Open-label, Investigator-initiated, Single arm, Phase 2 Trial Testing the Efficacy of Pembrolizumab in Patients with Metastatic Castration-resistant Prostate Cancer with Mismatch Repair Deficiency and Other Immune-sensitive Molecular Subtypes
Pasquale Rescigno, Maria D. Fenor de la Maza, Holly Tovey, Guillermo Villacampa, Fay Cafferty, Stephanie Burnett +34 more
2025· article· en· European Urology Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
3
citations
← previousnext →

How this was built: Screen · Findings · About